Whether you’ve traveled to Washington DC to enjoy the 22nd American Society of Gene & Cell Therapy (ASGCT) Annual Meeting or not, we’ve got you covered, with daily video updates and more!
Today's top abstracts
- Induced neural stem cell therapy: a treatment option for triple-negative breast cancer?
- Modified stem cells used to produce missing blood clotting factors
- Gene-edited cell lines could be compatible with 90% of the world
Today's daily update
Another day, another video update...and another special guest! @FreyaFSG is joined by @ASGCTherapy outgoing President Michele Calos to share the conference highlights from day 3! #ASGCT19 pic.twitter.com/qZiR4lVUq1— RegMedNet (@RegMedNet) May 1, 2019
Tomorrow's agenda highlight
- Exploiting the Regenerative Capacity of Liver for Nuclease-Free Genome Editing (Thursday, May 02, 11:15am) with Francesco Puzzo, Gustavo De Alencastro, Gijsbert Andries Patijn et al (Stanford University; CA, USA).